A Novel Device for Refeeding output in Stoma and Fistula Patients
The Feasibility of Re-infusion of Ileostomy and Fistula Output Within a Stoma Appliance to Reduce the Incidence of Fluid and Electrolyte Imbalances.
Asscociate Professor Gregory O' Grady
15 participants
Apr 4, 2018
Interventional
Conditions
Summary
This feasibility study aims to evaluate a novel pump device for the reinfusion of fistula output in its’ efficacy to prevent high-output related fluid and electrolyte imbalance. We will evaluate the rates of fluid and electrolyte derangements through clinical records in order to understand the efficacy of the device to prevent such effects of stomata and fistulae. As well as this we aim to understand the performance of the pump and patients' acceptance and tolerance of the device. Such information will be collated through interviews with participants as well as a daily ‘device diary’ which has been designed to collect parameters such as ease of use, duration of use and suggestions for improvement. Using feedback from users and issues encountered the device will be improved to fit the needs of its' users. Other outcomes we aim to evaluate include the effect of using the pump on individual's quality of life and recovery after re-establishment of bowel continuity. Through the results of this feasibility trial, we aim to improve the design and workflow of the device and develop future clinical trials.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A specially designed pump device is coupled to the distal limb of the stoma or fistula via a feeding tube. The device will be inserted by an experienced clinician in the hospital setting. Insertion of the device involves intubation of the distal limb of the stoma or fistula using a MIC feeding tube. This procedure takes approximately 10 to 30 minutes, depending on the ease of distal access. Participants would not need to stay in hospital overnight unless they are already inpatients. Patients will be instructed on how to use the pump by a study investigator. They will then be advised to use the pump on an 'as needed basis' to empty their stoma bags, over the three week trial period. A specific frequency of use is not prescribed as we wish to understand how the participants want to use the device, i.e whether they use the device to empty their appliance or whether they empty their appliance as normal into the toilet. Participants must also complete a daily ‘device diary’ which is provided to them. The device diary includes brief questions evaluating the convenience and ease of use of the device, feedback for improvement, symptoms as well as health related and stoma related quality of life questionnaires. The diary is also designed to qualitatively asses the acceptability of the device, including how patients incorporate its use into their daily life . In addition to this a study investigator will contact participants regularly to offer advice and support on using the device as well as to track the individual participant’s experience of using the device. Telephone follow up will be carried out by study investigators familiar with the device’s use and the frequency of these calls is negotiated between the participant and investigator however would be conducted at least once weekly over the test and trial period. From the feedback investigators gather from telephone interviews the design and use of the device will be improved and evaluated continuously such that overall the trial is an iterative process. Participants will be asked to use the device, at home or as an inpatient, to reinfuse as much of their stoma or fistula output as possible. How the pump is used however is an individual decision. The actual use of the pump and reasons for not using it will inform design and workflow improvements. Initially participants will undergo a ‘testing phase’ during which they will become familiar with using the device and any initial difficulties, such as device blockage, are addressed. This 'testing phase' is not specified and depends on the needs and circumstances of individual patients and can require up to one month. Once participants are comfortable with using the device a three week study period is initiated. During this time participants will complete their daily ‘device diary’ and any blood test results will be recorded from patient records.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12618001095257